PMID- 21177253 OWN - NLM STAT- MEDLINE DCOM- 20110617 LR - 20211020 IS - 1096-0929 (Electronic) IS - 1096-6080 (Print) IS - 1096-0929 (Linking) VI - 120 IP - 1 DP - 2011 Mar TI - Dipentyl phthalate dosing during sexual differentiation disrupts fetal testis function and postnatal development of the male Sprague-Dawley rat with greater relative potency than other phthalates. PG - 184-93 LID - 10.1093/toxsci/kfq386 [doi] AB - Phthalate esters (PEs) constitute a large class of plasticizer compounds that are widely used for many consumer product applications. Ten or more members of the PE class of compounds are known to induce male fetal endocrine toxicity and postnatal reproductive malformations by disrupting androgen production during the sexual differentiation period of development. An early study conducted in the rat pubertal model suggested that dipentyl phthalate (DPeP) may be a more potent testicular toxicant than some more extensively studied phthalates. Regulatory agencies require dose-response and potency data to facilitate risk assessment; however, very little data are currently available for DPeP. The goal of this study was to establish a more comprehensive data set for DPeP, focusing on dose-response and potency information for fetal and postnatal male reproductive endpoints. We dosed pregnant rats on gestational day (GD) 17 or GD 14-18 and subsequently evaluated fetal testicular testosterone (T) production on GD 17.5 and GD 18, respectively. We also dosed pregnant rats on GD 8-18 and evaluated early postnatal endpoints in male offspring. Comparison of these data to data previously obtained under similar conditions for di (2-ethylhexyl) phthalate indicates that DPeP is approximately eightfold more potent in reducing fetal T production and two- to threefold more potent in inducing development of early postnatal male reproductive malformations. Additionally, fetal testicular T production was more sensitive to inhibitory effects of DPeP exposure than was gene expression of target genes involved in male reproductive development, supporting the use of this endpoint as a critical effect in the risk assessment process. FAU - Hannas, Bethany R AU - Hannas BR AD - National Research Council Fellowship Program, National Health and Environmental Effects Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA. FAU - Furr, Johnathan AU - Furr J FAU - Lambright, Christy S AU - Lambright CS FAU - Wilson, Vickie S AU - Wilson VS FAU - Foster, Paul M D AU - Foster PM FAU - Gray, L Earl Jr AU - Gray LE Jr LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20101220 PL - United States TA - Toxicol Sci JT - Toxicological sciences : an official journal of the Society of Toxicology JID - 9805461 RN - 0 (Endocrine Disruptors) RN - 0 (Phthalic Acids) RN - 131-18-0 (di-n-pentyl phthalate) SB - IM MH - Animals MH - Animals, Newborn MH - Dose-Response Relationship, Drug MH - Endocrine Disruptors/*toxicity MH - Female MH - Gene Expression Regulation, Developmental/drug effects MH - Gestational Age MH - Male MH - Phthalic Acids/*toxicity MH - Pregnancy MH - Prenatal Exposure Delayed Effects/*chemically induced/genetics MH - Rats MH - Rats, Sprague-Dawley MH - Sex Differentiation/*drug effects/genetics MH - Testis/*drug effects/embryology/growth & development/metabolism PMC - PMC3044206 EDAT- 2010/12/24 06:00 MHDA- 2011/06/18 06:00 PMCR- 2012/03/01 CRDT- 2010/12/24 06:00 PHST- 2010/12/24 06:00 [entrez] PHST- 2010/12/24 06:00 [pubmed] PHST- 2011/06/18 06:00 [medline] PHST- 2012/03/01 00:00 [pmc-release] AID - kfq386 [pii] AID - 10.1093/toxsci/kfq386 [doi] PST - ppublish SO - Toxicol Sci. 2011 Mar;120(1):184-93. doi: 10.1093/toxsci/kfq386. Epub 2010 Dec 20.